1 – 10 of 78
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Bi-allelic NRXN1α deletion in microglia derived from iPSC of an autistic patient increases interleukin-6 production and impairs supporting function on neuronal networking
(
- Contribution to journal › Article
- 2024
-
Mark
On-Chip Neural Induction Boosts Neural Stem Cell Commitment : Toward a Pipeline for iPSC-Based Therapies
(
- Contribution to journal › Article
-
Mark
Unraveling the brain's response to COVID-19 : How SARS-CoV-2 afflicts dopaminergic neurons
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Pre-clinical evaluation of clinically relevant iPS cell derived neuroepithelial stem cells as an off-the-shelf cell therapy for spinal cord injury
(
- Contribution to journal › Article
-
Mark
High-throughput neural stem cell-based drug screening identifies S6K1 inhibition as a selective vulnerability in sonic hedgehog-medulloblastoma
(
- Contribution to journal › Article
- 2023
-
Mark
Screening autism-associated environmental factors in differentiating human neural progenitors with fractional factorial design-based transcriptomics
(
- Contribution to journal › Article
-
Mark
Deficiency of the Heterogeneous Nuclear Ribonucleoprotein U locus leads to delayed hindbrain neurogenesis
(
- Contribution to journal › Article
-
Mark
Advancing tomorrow’s therapies from research to reality : a comprehensive look at the ATMP pipeline at Lund Stem Cell Center
2023)(
- Book/Report › Report
-
Mark
Recommendations, guidelines, and best practice for the use of human induced pluripotent stem cells for neuropharmacological studies of neuropsychiatric disorders
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Multi-Omic Investigations of a 17-19 Translocation Links MINK1 Disruption to Autism, Epilepsy and Osteoporosis
(
- Contribution to journal › Article